The Cooper Heart Institute’s Cardiothoracic Surgery program has received "3 Star" ratings from the prestigious Society of Thoracic Surgeons (STS) in two separate categories: coronary artery bypass graft surgery (CABG) and aortic valve replacement surgery (AVR). It is the organization's highest quality ranking, and Cooper is among only two percent of participating hospitals with similar programs to earn “3 Star” ratings in both categories.
Today, Cooper University Hospital became the first hospital in New Jersey to implant a ground-breaking new technology, the Edwards Sapien Percutaneous Heart Valve.
The Cooper Heart Institute at Cooper University Hospital has been selected as one of the initial sites in the United States to implement a groundbreaking cardiovascular technology, the new Sapien Percutaneous Heart Valve.
This award is given only to hospitals that achieve 85 percent or higher adherence to all Get With The Guidelines Heart Failure Performance Achievement indicators to improve quality of patient care and outcomes. Cooper is the only hospital in the region to receive the Gold Plus achievement.
In a medical emergency, time is of the essence, especially when it comes to your heart. A new software called LifeNet is being implemented at Cooper University Hospital to shorten the length of time between identifying a heart attack and providing potentially life-saving treatment.
Today, Cooper University Hospital placed a Revo MRI™ SureScan® pacing system into a patient. This is the first MR-Conditional pacing system designed, tested and FDA approved for use in the Magnetic Resonance Imaging (MRI) environment.
Patient enrollment has begun in the RECITAL (A Patient Registry Evaluating Closure Following Access with the Arstasis One Access System) Study. The non-randomized, prospective, post-approval study anticipates enrolling up to 500 patients in at least seven medical centers in the United States, including Cooper.